Vascular Grafts Market Size, Share, Trends, Growth and Forecast 2024-2032

Global Vascular Grafts Industry: Key Statistics and Insights in 2024-2032

Summary:

• The global vascular grafts market size reached USD 1.9 Billion in 2023.
• The market is expected to reach 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.
• North America leads the market, accounting for the largest vascular grafts market share.
• Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.
• Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.
• The ongoing technological advancements in graft materials and design are supporting the market growth.
• The rising shift towards minimally invasive surgeries (MIS) is propelling the market growth.

Industry Trends and Drivers:

• Prevalence of Cardiovascular Diseases:

The increasing incidence of cardiovascular diseases (CVDs) worldwide represents one of the crucial factors impelling the market growth. These diseases often require surgical interventions that utilize vascular grafts.

• Technological Advancements in Graft Materials and Design:

The ongoing technological advancements in graft materials and design are supporting the market growth. Modern vascular grafts are biocompatible, durable, and designed to minimize complications like infections and graft rejection. The growing number of innovations, such as drug-eluting grafts and tissue-engineered vascular grafts, which are designed to integrate more seamlessly with the own tissues of the body, are offering a favorable market outlook. These advancements enhance the effectiveness and safety of vascular surgeries, leading to improved patient outcomes.

• Preference for Minimally Invasive Surgeries (MIS):

The rising shift towards minimally invasive surgeries (MIS) is propelling the market growth. MIS procedures, which include endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR), are less traumatic than traditional open surgeries and offer benefits like reduced hospital stay, lower risk of infections, and quicker recovery. This is encouraging the development and adoption of specialized vascular grafts suitable for these procedures. Additionally, patients and healthcare providers are increasingly favoring MIS due to these advantages, leading to the demand for compatible vascular grafts.

Request for a sample copy of this report: https://www.imarcgroup.com/vascular-grafts-market/requestsample

Vascular Grafts Market Report Segmentation:

By Product:

• Endovascular Stent Grafts
• Hemodialysis Access Grafts
• Coronary Artery By-Pass Grafts
• Vascular Grafts for Aorta Disease
• Peripheral Vascular Grafts

Endovascular stent grafts represent the largest segment as they are increasingly preferred for minimally invasive (MI) vascular procedures due to their efficacy and lower invasiveness.

By Raw Material:

• Polytetrafluoroethylene (PTFE)
• Polyester
• Polyurethane
• Biosynthetic

Polytetrafluoroethylene (PTFE) holds the biggest market share, attributed to its widespread use in vascular graft manufacturing, owing to its biocompatibility and durability.

By Application:

• Cardiac Aneurysm
• Kidney Failure
• Vascular Occlusion
• Coronary Artery Disease

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

By End User:

• Hospitals
• Ambulatory Surgical Centers (ASCs)

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America dominates the market, which can be accredited to the increasing adoption of advanced vascular graft technologies and a rising prevalence of vascular diseases in the region.

Top Vascular Grafts Market Leaders: The vascular grafts market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

• Abbott Laboratories
• B. Braun SE (B. Braun Holding GmbH & Co. KG)
• Becton, Dickinson & Company
• Cook Group Incorporated
• Cordis
• CryoLife Inc.
• Getinge AB
• Heat Medical Europe BV
• LeMaitre Vascular
• Medtronic plc
• Terumo Corporation
• W.L. Gore & Associates Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163